Vertex Pharmaceuticals Incorporated (VRTX) closed at $505.55 on August 16, 2026, registering no change from the prior session's close. The stock's flat daily performance came as the broader market continued to digest recent economic signals.
Over a longer horizon, Vertex shares have demonstrated consistent upward momentum. The stock gained 1.85% over the past seven days and advanced 4.10% over the trailing 30-day period, reflecting a steady build in share price.
The company's market capitalization stood at $128.19 billion as of the close, underscoring Vertex's position as one of the larger players in the biopharmaceutical sector.
The combination of near-term stability and positive medium-term performance places VRTX among the more consistent names in its peer group over the measured timeframes.
